伐地那非是一种高选择性的新型磷酸二酯酶5抑制剂，是广泛ED人群的一线治疗药物。
Vardenafil, a novel and highly selective phosphodiesterase 5 inhibitor, is the first line therapy for the broad ED population.
伐地那非是一种新型高选择性磷酸二酯酶5型抑制剂，它对心血管系统的安全性已被多项临床试验所证实。
Vardenafil, as a novel and highly selective phosphodiesterase 5 inhibitor, has been proved by many clinical trials to be quite safe for the cardiovascular system.
氟伐地汀组总胆固醇、低密度脂蛋白胆固醇、白介素- 6、C -反应蛋白水平显著降低，而安慰剂组无变化。
Levels of total cholesterol, low-density lipoprotein cholesterol, interleukin-6, and C-reactive protein were significantly decreased in the fluvastatin group but were unchanged in the placebo group.
应用推荐